Redefining the future of pharmaceutical production with cutting-edge digital technology, collaborative expertise, and more sustainable manufacturing practices.

We have today opened our Medicines Manufacturing Innovation Centre facility in Glasgow City Region, Scotland. The £ 88 million Centre is bringing world-leading science and technology expertise under one roof to help accelerate state-of-the-art solutions to some of the biggest challenges in medicines development and manufacturing.

2021年11月3日 · The Centre for Process Innovation (CPI), the University of Strathclyde, Scottish Enterprise, Innovate UK, AstraZeneca and GlaxoSmithKline (GSK) have partnered to open the Medicines Manufacturing Innovation Centre (MMIC) in Renfrewshire, Scotland.

An innovative research, development and manufacturing facility, the new Medicines Manufacturing Innovation Centre (MMIC) in Renfrewshire will support the UK’s pharmaceutical and fine chemicals industries in accelerating a new generation of manufacturing processes.

Alongside partners in industry, government and academia, CPI has created the Medicines Manufacturing Innovation Centre to develop, prove and commercialise disruptive technologies for the pharmaceutical industry. We operate a model …

2022年12月1日 · The Centre is a unique collaboration between technology innovation catalyst CPI and 23 partner organisations from across the pharma sector, business, academia, and government agencies. Its ‘Grand Challenge’ business model follows the UK Life Sciences Strategy roadmap, combining ideas from the pharma and technology sectors to help tackle ...

Address and directions for CPI's Medicines Manufacturing Innovation Centre at Paisley, Glasgow..

2021年2月4日 · The Medicines Manufacturing Innovation Centre (MMIC) has today launched a scalable, sustainable and more cost-effective way to make oligonucleotides. Oligonucleotides are short strands of synthetic DNA or RNA that can be used to tackle both rare and more common diseases. They work by interfering with how genes are expressed.

Located in Renfrewshire, at the heart of the emerging Advanced Manufacturing Innovation District Scotland (AMIDS), the £ 35 million facility is set to develop next-generation pharmaceutical manufacturing processes to drive forward innovation in the medicines supply chain.

MMIC can support Scottish companies with their pharma manufacturing and digital innovation projects, including access to technical expertise and help securing project funding. CPI's Bid Development team helps SMEs aligned with its capabilities identify relevant grant funding streams and build consortia to drive collaborative research and ...